Morgan M. Stanton in

Morgan M. Stanton

Questioner · DISC type c
Strategic Advisor at Self-employed
📍 San Francisco Bay Area, United States

Morgan Stanton is the CEO and Founder of Opal Therapeutics, a biotech company pioneering drug discovery for womens reproductive health. With a Ph. D. in Chemistry from Worcester Polytechnic Institute, she leverages her deep expertise in tissue engineering and organoid models to develop novel therapeutics for chronic gynecological disorders.

Her passion for this field is deeply personal, sparked by her own challenging five-year journey with uterine fibroids. This experience fuels her mission to address the significant research and funding gaps in womens health, aiming to develop more effective and less invasive treatments for conditions like endometriosis and fibroids.

To advance her research, she created a unique biobank collection method, personally acting as a courier to pick up menstrual samples from donors around the Bay Area.

Read the full overview →
Experience
17 Years
Current Role
Strategic Advisor
Job Level
Leadership
Location
San Francisco Bay Area, United States
Personality Overview

How Morgan shows up

Not Easily Convinced
Value Seeker
Systematic

They prefer to analyze every situation thoroughly.
 They are more likely than others to negotiate on pricing and terms. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point.

Priorities

Topics Morgan cares about

Women's Health Innovation
Her company, Opal Therapeutics, is dedicated to developing new drugs for understudied gynecological conditions like uterine fibroids and endometriosis.
Organoid Technology
She develops "uterus in a dish" models, leveraging her past experience creating scalable brain organoid platforms to accelerate drug screening and development.
+5 more topics Login to view topics
Career

Work history

10-2023
Strategic Advisor
Self-employed
9-2023
Chief Executive Officer
Opal Therapeutics
1-2023 - 10-2023
Director of Discovery Biology
Herophilus
2-2019 - 1-2023
Principal Scientist
Herophilus
1-2018 - 1-2019
Senior Biomaterials Scientist
VitroLabs Inc
In the press

Media appearances

Speaker Biography – Morgan M. Stanton, CEO, Opal Therapeutics. Featured in Discovery on Target Conference
See now
Opal Therapeutics – San Francisco Techstars ’24 Demo Day (featuring CEO Morgan M. Stanton). Featured in YouTube
+1 more appearances Login to view media
Education
2009 - 2014
Ph.D.
Worcester Polytechnic Institute
2005 - 2009
B.S.
University of New Hampshire
Social presence
in
Behavioral profile

DISC profile (public)

c

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

Other Self-employed Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Morgan. Free, 10 seconds.